01 3Benza
Main Therapeutic Indication : Anti-Cholinergic
Currency : USD
2016 Revenue in Millions : 105
2015 Revenue in Millions : 71
Growth (%) : 48
Main Therapeutic Indication : Anti-cholinergic
Currency : USD
2017 Revenue in Millions : 92
2016 Revenue in Millions : 112
Growth (%) : -18
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 67
2017 Revenue in Millions : 86
Growth (%) : -23%
LOOKING FOR A SUPPLIER?